Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Recurrence rates of urinary calculi according to stone composition and morphology.

Daudon M, Jungers P, Bazin D, Williams JC Jr.

Urolithiasis. 2018 Oct;46(5):459-470. doi: 10.1007/s00240-018-1043-0. Epub 2018 Feb 1.

2.

Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Daudon M, Frochot V, Bazin D, Jungers P.

Drugs. 2018 Feb;78(2):163-201. doi: 10.1007/s40265-017-0853-7. Review.

PMID:
29264783
3.

Validation of Surrogates of Urine Osmolality in Population Studies.

Youhanna S, Bankir L, Jungers P, Porteous D, Polasek O, Bochud M, Hayward C, Devuyst O.

Am J Nephrol. 2017;46(1):26-36. doi: 10.1159/000475769. Epub 2017 Jun 7.

4.

Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease.

Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby N, Bankir L, Bichet DG.

J Clin Endocrinol Metab. 2014 Dec;99(12):4656-63. doi: 10.1210/jc.2014-2295.

PMID:
25202818
5.

The pathogenesis of Randall's plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy.

Carpentier X, Bazin D, Jungers P, Reguer S, Thiaudière D, Daudon M.

J Synchrotron Radiat. 2010 May;17(3):374-9. doi: 10.1107/S0909049510003791. Epub 2010 Mar 18.

PMID:
20400836
6.

Stone formation and pregnancy: pathophysiological insights gained from morphoconstitutional stone analysis.

Meria P, Hadjadj H, Jungers P, Daudon M; Members of the French Urological Association Urolithiasis Committee.

J Urol. 2010 Apr;183(4):1412-6. doi: 10.1016/j.juro.2009.12.016. Epub 2010 Feb 20.

PMID:
20172556
7.

Nonprogressive kidney dysfunction and outcomes in older adults with chronic kidney disease.

El-Ghoul B, Elie C, Sqalli T, Jungers P, Daudon M, Grünfeld JP, Lesavre P, Joly D.

J Am Geriatr Soc. 2009 Dec;57(12):2217-23. doi: 10.1111/j.1532-5415.2009.02561.x.

PMID:
20121987
8.

Revisiting the localisation of Zn(2+) cations sorbed on pathological apatite calcifications made through X-ray absorption spectroscopy.

Bazin D, Carpentier X, Brocheriou I, Dorfmuller P, Aubert S, Chappard C, Thiaudière D, Reguer S, Waychunas G, Jungers P, Daudon M.

Biochimie. 2009 Oct;91(10):1294-300. doi: 10.1016/j.biochi.2009.05.009. Epub 2009 Jun 2.

PMID:
19497348
9.

Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology.

Carpentier X, Daudon M, Traxer O, Jungers P, Mazouyes A, Matzen G, Véron E, Bazin D.

Urology. 2009 May;73(5):968-75. doi: 10.1016/j.urology.2008.12.049.

PMID:
19394492
10.

Stones in primary hyperoxaluria--a clarification.

Daudon M, Jungers P, Bazin D.

N Engl J Med. 2009 Apr 16;360(16):1680. doi: 10.1056/NEJMc0900365. No abstract available.

PMID:
19369680
11.

Diffraction techniques and vibrational spectroscopy opportunities to characterise bones.

Bazin D, Chappard C, Combes C, Carpentier X, Rouzière S, André G, Matzen G, Allix M, Thiaudière D, Reguer S, Jungers P, Daudon M.

Osteoporos Int. 2009 Jun;20(6):1065-75. doi: 10.1007/s00198-009-0868-3. Review. No abstract available.

PMID:
19340497
12.

Very first tests on SOLEIL regarding the Zn environment in pathological calcifications made of apatite determined by X-ray absorption spectroscopy.

Bazin D, Carpentier X, Traxer O, Thiaudière D, Somogyi A, Reguer S, Waychunas G, Jungers P, Daudon M.

J Synchrotron Radiat. 2008 Sep;15(Pt 5):506-9. doi: 10.1107/S0909049508014556. Epub 2008 Jul 11.

PMID:
18728322
13.

Peculiar morphology of stones in primary hyperoxaluria.

Daudon M, Jungers P, Bazin D.

N Engl J Med. 2008 Jul 3;359(1):100-2. doi: 10.1056/NEJMc0800990. No abstract available.

PMID:
18596285
14.

[Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].

Jungers P, Joly D, Blanchard A, Courbebaisse M, Knebelmann B, Daudon M.

Nephrol Ther. 2008 Jul;4(4):231-55. doi: 10.1016/j.nephro.2007.12.005. Epub 2008 May 22. Review. French.

PMID:
18499551
15.

Diabetes and nephrolithiasis.

Daudon M, Jungers P.

Curr Diab Rep. 2007 Dec;7(6):443-8.

PMID:
18255008
16.

[Difference in urine concentration according to gender and ethnicity: possible involvement in the different susceptibility to various renal and cardiovascular diseases].

Perucca J, Bouby N, Valeix P, Jungers P, Bankir L.

Nephrol Ther. 2008 Jun;4(3):160-72. doi: 10.1016/j.nephro.2007.11.003. Epub 2008 Feb 20. Review. French.

PMID:
18243833
17.

[Encrusted pyelitis: early diagnosis facilitates conservative management].

Meria P, Jungers P.

Presse Med. 2008 Jan;37(1 Pt 2):85-7. Epub 2007 Nov 5. Review. French.

PMID:
17980549
18.

Heavy elements in urinary stones.

Bazin D, Chevallier P, Matzen G, Jungers P, Daudon M.

Urol Res. 2007 Aug;35(4):179-84. Epub 2007 May 10.

PMID:
17492279
19.

Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.

Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.

Nephrol Dial Transplant. 2007 Apr;22(4):1115-22. Epub 2007 Jan 5.

PMID:
17205957
20.

[Nephrolithiasis-induced ESRD: frequency, causes and prevention].

Jungers P, Joly D, Barbey F, Choukroun G, Daudon M.

Nephrol Ther. 2005 Nov;1(5):301-10. Epub 2005 Oct 3. French.

PMID:
16895699
21.

Type 2 diabetes increases the risk for uric acid stones.

Daudon M, Traxer O, Conort P, Lacour B, Jungers P.

J Am Soc Nephrol. 2006 Jul;17(7):2026-33. Epub 2006 Jun 14.

22.

Influence of body size on urinary stone composition in men and women.

Daudon M, Lacour B, Jungers P.

Urol Res. 2006 Jun;34(3):193-9. Epub 2006 Feb 11.

PMID:
16474948
23.

[Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].

Jungers P, Joly D, Nguyen-Khoa T, Mothu N, Bassilios N, Grünfeld JP.

Presse Med. 2006 Jan;35(1 Pt 1):17-22. French.

24.
25.

Serial crystalluria determination and the risk of recurrence in calcium stone formers.

Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P.

Kidney Int. 2005 May;67(5):1934-43.

26.

Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.

Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM, Jungers P.

Am J Kidney Dis. 2005 Jan;45(1):39-47.

PMID:
15696442
27.

High prevalence of uric acid calculi in diabetic stone formers.

Daudon M, Lacour B, Jungers P.

Nephrol Dial Transplant. 2005 Feb;20(2):468-9. No abstract available.

PMID:
15673704
28.

Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi.

Daudon M, Jungers P.

Nephron Physiol. 2004;98(2):p31-6. Review.

PMID:
15499212
29.

[Drug-induced lithiasis].

Daudon M, Jungers P.

Rev Med Suisse Romande. 2004 Aug;124(8):483-90. Review. French. No abstract available.

PMID:
15495472
30.

[Value of the study of crystalluria in clinical practice].

Daudon M, Barbey F, Jungers P.

Rev Med Suisse Romande. 2004 Aug;124(8):455-9. Review. French. No abstract available.

PMID:
15495467
31.

[Lithogenesis].

Daudon M, Barbey F, Jungers P.

Rev Med Suisse Romande. 2004 Aug;124(8):439-44. Review. French. No abstract available.

PMID:
15495465
32.

ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.

Jungers P, Joly D, Barbey F, Choukroun G, Daudon M.

Am J Kidney Dis. 2004 Nov;44(5):799-805.

PMID:
15492945
33.

Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.

Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noël LH, Guérin AP, London GM, Jungers P.

Kidney Int. 2004 Oct;66(4):1606-12.

34.

[Clinical value of crystalluria study].

Daudon M, Jungers P, Lacour B.

Ann Biol Clin (Paris). 2004 Jul-Aug;62(4):379-93. Review. French.

35.

Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach.

Daudon M, Doré JC, Jungers P, Lacour B.

Urol Res. 2004 Jun;32(3):241-7. Epub 2004 May 4.

PMID:
15127165
36.

[Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality?].

Daudon M, Cohen-Solal F, Lacour B, Jungers P.

Prog Urol. 2003 Dec;13(6):1320-9. French.

PMID:
15000307
37.

Drug-induced renal calculi: epidemiology, prevention and management.

Daudon M, Jungers P.

Drugs. 2004;64(3):245-75. Review.

PMID:
14871169
38.

Cystine crystal volume determination: a useful tool in the management of cystinuric patients.

Daudon M, Cohen-Solal F, Barbey F, Gagnadoux MF, Knebelmann B, Jungers P.

Urol Res. 2003 Jul;31(3):207-11. Epub 2003 May 14.

PMID:
12748836
39.

[Cardioprotection: an essential component for predialysis chronic renal failure treatment].

Jungers P, Qualim Z, Nguyen-Khoa T, Massy Z, London G.

Nephrologie. 2003;24(2):79-88. Review. French.

PMID:
12723513
40.

Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes.

Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M, Grünfeld JP, Jungers P.

J Am Soc Nephrol. 2003 Apr;14(4):1012-21.

41.

[Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].

Jungers PY, Nguyen-Khoa T, Joly D, Choukroun G, Massy ZA, Jungers P.

Presse Med. 2003 Feb 8;32(5):212-6. French.

PMID:
12610461
42.

[Drinking water and urinary stones. Which drinking water and which modalities of diuresis?].

Hubert J, Hubert C, Jungers P, Daudon M, Hartemann P.

Prog Urol. 2002 Sep;12(4):692-9. French.

PMID:
12463138
43.

Immune system dysregulation in uremia: role of oxidative stress.

Descamps-Latscha B, Jungers P, Witko-Sarsat V.

Blood Purif. 2002;20(5):481-4. Review.

PMID:
12207098
44.

Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients.

Jungers PY, Robino C, Choukroun G, Nguyen-Khoa T, Massy ZA, Jungers P.

Nephrol Dial Transplant. 2002 Sep;17(9):1621-7.

PMID:
12198213
45.

[Urinary lithiasis of medical origin].

Cohen-Solal F, Abdelmoula J, Hoarau MP, Jungers P, Lacour B, Daudon M.

Therapie. 2001 Nov-Dec;56(6):743-50. French.

PMID:
11878101
46.

Late referral: loss of chance for the patient, loss of money for society.

Jungers P.

Nephrol Dial Transplant. 2002 Mar;17(3):371-5. Review. No abstract available.

PMID:
11865079
47.

Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients.

Jungers P, Massy ZA, Nguyen-Khoa T, Choukroun G, Robino C, Fakhouri F, Touam M, Nguyen AT, Grünfeld JP.

Nephrol Dial Transplant. 2001 Dec;16(12):2357-64.

PMID:
11733627
48.

[Course of chronic renal failure epidemiology and prediction of maintenance dialysis needs in France].

Jungers P, Robino C, Choukroun G, Touam M, Fakhouri F, Grünfeld JP.

Nephrologie. 2001;22(3):91-7. Review. French.

PMID:
11436669
49.

[Indications and preparations for kidney dialysis].

Jungers P, Robino C, Choukroun G, Man NK.

Rev Prat. 2001 Feb 28;51(4):391-5. French.

PMID:
11355603
50.

[Cystine lithiasis: physiopathology and medical treatment].

Jungers P, Joly D, Gagnadoux MF, Daudon M.

Prog Urol. 2001 Feb;11(1):122-6. Review. French. No abstract available.

PMID:
11296632

Supplemental Content

Loading ...
Support Center